Article
Impaired humoral immunity to BQ.1.1 in convalescent and vaccinated patients
2023-01-03
Abstract excerpt
Determining SARS-CoV-2 immunity is critical to assess COVID-19 risk and the need for prevention and mitigation strategies. We measured SARS-CoV-2 Spike/Nucleocapsid seroprevalence and serum neutralizing activity against Wu01, BA.4/5 and BQ.1.1 in 1,411 individuals who received medical treatment in five emergency departments in North Rhine-Westphalia, Germany. We detected Spike-IgG in 95.6%, Nucleocapsid-IgG in 24....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 269dc55d-8207-5fb0-8a51-55a00a0de114
- DOI
- 10.1101/2022.12.31.22284088
